Arcadia Biosciences Inc (RKDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 314 | 281 | 309 | 416 | 392 |
| Cost of Goods | 1,841 | 1,490 | 132 | 560 | 177 |
| Gross Profit | -1,527 | -1,209 | 177 | -144 | 215 |
| Operating Expenses | 6,895 | 6,157 | 6,099 | 4,404 | 6,585 |
| Operating Income | -7,581 | -6,876 | -5,790 | -3,988 | -6,193 |
| Interest Expense | 23 | 6 | 3 | 2 | 3 |
| Other Income | 448 | -3,022 | 8,233 | -2,334 | -7,994 |
| Pre-tax Income | -7,156 | -9,904 | 2,440 | -6,324 | -14,190 |
| Income Tax | 9 | -10 | 17 | -13 | -3 |
| Net Income Continuous | -7,165 | -9,894 | 2,423 | -6,311 | -14,187 |
| Minority Interests | -774 | -205 | -102 | N/A | N/A |
| Net Income | $-6,391 | $-9,689 | $2,525 | $-6,243 | $-14,187 |
| EPS Basic Total Ops | -24.00 | -41.60 | 11.60 | -27.60 | -81.60 |
| EPS Basic Continuous Ops | -26.74 | -42.43 | 11.20 | -27.67 | -81.73 |
| EPS Diluted Total Ops | -24.00 | -41.60 | 11.60 | -27.60 | -81.60 |
| EPS Diluted Continuous Ops | -26.74 | -42.43 | 11.17 | -27.67 | -81.73 |
| EBITDA(a) | $-7,107 | $-6,512 | $-5,532 | $-3,808 | $-5,994 |